(2-281) Exploring Pipeline Therapies: Are Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) and Glucose-dependent Insulinotropic Polypeptides (GIP) the Next Frontier for Metabolic Liver Disease?
Monday, December 9, 2024
10:45 AM – 11:45 AM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Investigational Drugs/Research
